stocks logo

PHLT Valuation

Performant Healthcare Inc
$
7.620
0(0.000%)1D
  • Overview
  • Forecast
  • Valuation
  • Earnings

PHLT Relative Valuation

PHLT's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, PHLT is overvalued; if below, it's undervalued.
AI Stock Picker

Historical Valuation

Performant Healthcare Inc (PHLT) is now in the Overvalued zone, suggesting that its current forward PS ratio of 4.31 is considered Overvalued compared with the five-year average of -62.85. The fair price of Performant Healthcare Inc (PHLT) is between 2.31 to 5.05 according to relative valuation methord. Compared to the current price of 7.62 USD , Performant Healthcare Inc is Overvalued By 50.78%.
Relative Value
Fair Zone
2.31-5.05
Current Price:7.62
50.78%
Overvalued
-179.29
PE
1Y
3Y
5Y
Trailing
Forward
51.62
EV/EBITDA
Performant Healthcare Inc. (PHLT) has a current EV/EBITDA of 51.62. The 5-year average EV/EBITDA is 30.13. The thresholds are as follows: Strongly Undervalued below 10.70, Undervalued between 10.70 and 20.42, Fairly Valued between 39.85 and 20.42, Overvalued between 39.85 and 49.56, and Strongly Overvalued above 49.56. The current Forward EV/EBITDA of 51.62 falls within the Strongly Overvalued range.
-269.09
EV/EBIT
Performant Healthcare Inc. (PHLT) has a current EV/EBIT of -269.09. The 5-year average EV/EBIT is -85.80. The thresholds are as follows: Strongly Undervalued below -249.21, Undervalued between -249.21 and -167.51, Fairly Valued between -4.09 and -167.51, Overvalued between -4.09 and 77.61, and Strongly Overvalued above 77.61. The current Forward EV/EBIT of -269.09 falls within the Strongly Undervalued range.
4.31
PS
Performant Healthcare Inc. (PHLT) has a current PS of 4.31. The 5-year average PS is 2.09. The thresholds are as follows: Strongly Undervalued below 0.15, Undervalued between 0.15 and 1.12, Fairly Valued between 3.06 and 1.12, Overvalued between 3.06 and 4.03, and Strongly Overvalued above 4.03. The current Forward PS of 4.31 falls within the Strongly Overvalued range.
93.42
P/OCF
Performant Healthcare Inc. (PHLT) has a current P/OCF of 93.42. The 5-year average P/OCF is 55.45. The thresholds are as follows: Strongly Undervalued below 16.32, Undervalued between 16.32 and 35.88, Fairly Valued between 75.01 and 35.88, Overvalued between 75.01 and 94.57, and Strongly Overvalued above 94.57. The current Forward P/OCF of 93.42 falls within the Overvalued range.
1333.51
P/FCF
Performant Healthcare Inc. (PHLT) has a current P/FCF of 1333.51. The 5-year average P/FCF is 93.71. The thresholds are as follows: Strongly Undervalued below -1128.97, Undervalued between -1128.97 and -517.63, Fairly Valued between 705.05 and -517.63, Overvalued between 705.05 and 1316.39, and Strongly Overvalued above 1316.39. The current Forward P/FCF of 1333.51 falls within the Strongly Overvalued range.
Performant Healthcare Inc (PHLT) has a current Price-to-Book (P/B) ratio of 7.32. Compared to its 3-year average P/B ratio of 3.60 , the current P/B ratio is approximately 103.57% higher. Relative to its 5-year average P/B ratio of 3.60, the current P/B ratio is about 103.57% higher. Performant Healthcare Inc (PHLT) has a Forward Free Cash Flow (FCF) yield of approximately -0.07%. Compared to its 3-year average FCF yield of -0.01%, the current FCF yield is approximately 625.98% lower. Relative to its 5-year average FCF yield of -0.01% , the current FCF yield is about 625.98% lower.
7.32
P/B
Median3y
3.60
Median5y
3.60
-0.07
FCF Yield
Median3y
-0.01
Median5y
-0.01
Financial AI Agent

Competitors Valuation Multiple

The average P/S ratio for PHLT's competitors is 1.78, providing a benchmark for relative valuation. Performant Healthcare Inc Corp (PHLT) exhibits a P/S ratio of 4.31, which is 141.56% above the industry average. Given its robust revenue growth of 28.75%, this premium appears sustainable.
Intellectia AI SwingMax

Performance Decomposition

1Y
3Y
5Y
Market capitalization of PHLT increased by 103.74% over the past 1 year. The primary factor behind the change was an decrease in P/E Change from -204.88 to -673.86.
The secondary factor is the Revenue Growth, contributed 28.75%to the performance.
Overall, the performance of PHLT in the past 1 year is driven by P/E Change. Which is more unsustainable.
28.75%
29.36M → 37.80M
Revenue Growth
+
-153.92%
-10.20 → 5.50
Margin Expansion
+
228.91%
-204.88 → -673.86
P/E Change
=
103.74%
3.74 → 7.62
Mkt Cap Growth

FAQ

arrow icon

Is Performant Healthcare Inc (PHLT) currently overvalued or undervalued?

Performant Healthcare Inc (PHLT) is now in the Overvalued zone, suggesting that its current forward PS ratio of 4.31 is considered Overvalued compared with the five-year average of -62.85. The fair price of Performant Healthcare Inc (PHLT) is between 2.31 to 5.05 according to relative valuation methord. Compared to the current price of 7.62 USD , Performant Healthcare Inc is Overvalued By 50.78% .
arrow icon

What is Performant Healthcare Inc (PHLT) fair value?

arrow icon

How does PHLT's valuation metrics compare to the industry average?

arrow icon

What is the current P/B ratio for Performant Healthcare Inc (PHLT) as of Sep 03 2025?

arrow icon

What is the current FCF Yield for Performant Healthcare Inc (PHLT) as of Sep 03 2025?

arrow icon

What is the current Forward P/E ratio for Performant Healthcare Inc (PHLT) as of Sep 03 2025?

arrow icon

What is the current Forward P/S ratio for Performant Healthcare Inc (PHLT) as of Sep 03 2025?